GlassScriptPhysician profile
Matthew David Burger
NPI 1932195856
$12,922.44
in general payments reported to CMS, 2019-2025
50 companies · $2,100 in 2025
The $2,100 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,236 · 2022: $2,665 · 2023: $3,039 · 2024: $2,883 · 2025: $2,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,648 · Education: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,648.05 |
| Education | $374.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,910.04 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $1,288.39 | 2021-2024 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $1,152.39 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $1,075.64 | 2021-2025 | Erleada |
| Endo Pharmaceuticals INC. | $566.66 | 2021-2024 | Xiaflex, Aveed, Edex |
| Myovant Sciences INC. | $503.91 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $452.24 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $413.16 | 2021-2025 | Lynparza |
| Verity Pharmaceuticals INC. | $410.49 | 2022-2025 | Trelstar |
| Antares Pharma, INC. | $402.58 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $399.79 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $398.35 | 2022-2025 | |
| Urovant Sciences INC | $352.77 | 2021-2022 | |
| Tolmar, INC. | $350.13 | 2023-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $295.92 | 2021-2023 | Prolaris, Precisetumor |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $229.02 | 2021-2022 | |
| Axonics, INC. | $226.40 | 2021-2024 | Axonics |
| Pfizer INC. | $224.51 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $202.09 | 2023-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $201.50 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $200.32 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Olympus America INC. | $191.80 | 2022-2025 | Itind System, Olympus |
| Boston Scientific Corporation | $177.42 | 2021-2025 | Axonics, Solyx Sis System, Ams 700 |
| Abbvie INC. | $135.12 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $119.42 | 2024-2025 | |
| Blue Earth Diagnostics | $102.41 | 2021-2022 | |
| Urogen Pharma, INC. | $94.28 | 2023-2025 | Jelmyto |
| Accord Healthcare, INC. | $90.75 | 2022-2023 | |
| Hollister Incorporated | $87.97 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $80.54 | 2022-2023 | Seglentis |
| Travere Therapeutics, INC. | $67.56 | 2021-2023 | Thiola |
| Halozyme INC | $50.26 | 2023 | |
| Palette Life Sciences, INC. | $41.51 | 2022 | |
| Agiliti Surgical, INC. | $41.28 | 2023-2025 | Trinity, Cryocare Cs, Sonablate |
| Ethicon US, LLC | $40.94 | 2024 | Stratafix |
| C. R. Bard, INC. & Subsidiaries | $40.30 | 2022 | |
| Immunitybio, INC. | $38.65 | 2024-2025 | |
| Medtronic, INC. | $37.68 | 2022-2023 | Interstim |
| Genzyme Corporation | $30.97 | 2023 | |
| Smith+Nephew, INC. | $25.27 | 2023 | Stravix Pl |
| Clarus Therapeutics INC. | $21.15 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.94 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.71 | 2025 | Azmiro |
| Coloplast Corp | $17.93 | 2025 | |
| Dentsply Ih INC. | $16.75 | 2021 | |
| Dentsply Ih Ab | $15.59 | 2021 | |
| Amgen INC. | $15.51 | 2021 | |
| Teleflex LLC | $15.19 | 2021 | |
| Acerus Pharmaceuticals Corporation | $15.11 | 2021 | |
| Laborie Medical Technologies Corp. | $13.13 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Burger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.